Comparison of COVID-19 hospitalization costs across care pathways: a patient-level time-driven activity-based costing analysis in a Brazilian hospital.
Ricardo Bertoglio CardosoMiriam Allein Zago MarcolinoMilena Soriano MarcolinoCamila Felix FortisLeila Beltrami MoreiraAna Paula CoutinhoNadine Oliveira ClausellJunaid NabiRobert S KaplanAna Paula Beck da Silva EtgesCarísi Anne PolanczykPublished in: BMC health services research (2023)
This is one of the first microcosting study for COVID-19 that applied the TDABC methodology and demonstrated how patient-level costs vary as a function of the care pathways followed by patients. These findings can be used to develop value reimbursement strategies that will inform sustainable health policies in middle-income countries such as Brazil.
Keyphrases
- healthcare
- coronavirus disease
- sars cov
- public health
- end stage renal disease
- palliative care
- case report
- ejection fraction
- quality improvement
- mental health
- chronic kidney disease
- prognostic factors
- physical activity
- pain management
- peritoneal dialysis
- emergency department
- respiratory syndrome coronavirus
- health information
- patient reported outcomes
- drug induced
- data analysis